Parsey Merdad 4
4 · GILEAD SCIENCES, INC. · Filed Dec 11, 2024
Insider Transaction Report
Form 4
Parsey Merdad
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2024-12-10$92.34/sh−1,771$163,534→ 82,850 total - Exercise/Conversion
Common Stock
2024-12-10+3,820→ 84,621 total - Exercise/Conversion
Restricted Stock Unit
2024-12-10−3,820→ 36,753 total→ Common Stock (3,820 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.